Complete Transurethral Resection before Radical Cystectomy May Improve Oncological Outcomes

Author:

Graffeille Vivien,Verhoest Grégory,Gryn Alexandre,Kammerer-Jacquet Solène-Florence,Alimi Quentin,Beauval Jean-Baptiste,Beuzit Luc,Pradère BenjaminORCID,Thoulouzan Matthieu,Khene Zine Eddine,Guille François,Rioux-Leclercq Nathalie,Mathieu Romain,Gamé Xavier,Bensalah Karim,Soulié Michel,Roumiguié Mathieu,Peyronnet Benoit

Abstract

<b><i>Objectives:</i></b> The objective of this study was to assess the impact of complete transurethral resection of bladder tumors (TURBTs) before radical cystectomy on pathological and oncological outcomes of patients with muscle-invasive bladder cancer (MIBC) and high-risk non-MIBC. <b><i>Materials and Methods:</i></b> The charts of all patients who underwent radical cystectomy for bladder cancer in 2 academic departments of urology between 1996 and 2016 were retrospectively reviewed. Patients were divided into 2 groups according to the completeness of the last endoscopic resection before radical cystectomy: macroscopically complete transurethral resection (complete) or macroscopically incomplete transurethral resection (incomplete). The primary end point was the recurrence-free survival (RFS). Secondary end points included cancer-specific survival (CSS) and rates of pT0 and downstaging. <b><i>Results:</i></b> Out of 486 patients included for analysis, the TURBT immediately preceding radical cystectomy was considered macroscopically complete in 253 patients (52.1%) and incomplete in 233 patients (47.9%). In multivariate analysis, macroscopically complete TURBT was the strongest predictor of both pT0 disease (OR = 3.1; <i>p</i> = 0.02) and downstaging (OR = 7.1; <i>p</i> &#x3c; 0.0001). After a median follow-up of 41 months, macroscopically complete TURBT was associated with better RFS (5-year RFS: 57 vs. 37%; <i>p</i> &#x3c; 0.0001) and CSS (5-year CSS: 70.8 vs. 54.5%; <i>p</i> = 0.002). In multivariate analysis adjusting for multifocality, weight of endoscopic resection specimen, cT4 stage on preoperative imaging, interval between endoscopic resection and radical cystectomy, neoadjuvant chemotherapy, pT stage, and associated carcinoma in situ, macroscopically complete endoscopic resection remained the main predictor of better RFS (HR = 0.4; <i>p</i> = 0.0003) and the only preoperative factor associated with CSS (HR = 0.5; <i>p</i> = 0.01). <b><i>Conclusion:</i></b> A macroscopically complete TURBT immediately preceding radical cystectomy may improve pathological and oncological outcomes in patients with MIBC and high-risk MIBC.

Publisher

S. Karger AG

Subject

Urology

Reference21 articles.

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30.

2. Babjuk M, Böhle A, Burger M, Capoun O, Cohen D, Compérat EM, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol. 2017;71(3):447–61.

3. Woldu SL, Bagrodia A, Lotan Y. Guideline of guidelines: non-muscle-invasive bladder cancer. BJU Int. 2017;119(3):371–80.

4. Richards KA, Smith ND, Steinberg GD. The importance of transurethral resection of bladder tumor in the management of nonmuscle invasive bladder cancer: a systematic review of novel technologies. J Urol. 2014;191(6):1655–64.

5. Russell CM, Lebastchi AH, Borza T, Spratt DE, Morgan TM. The role of transurethral resection in trimodal therapy for muscle-invasive bladder cancer. Bladder Cancer. 2016;2(4):381–94.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3